Shengjuan Lu
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Retraction notice to "Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis" [Biomedicine & Pharmacotherapy 82 (2016) 669-676].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 08, 2026
Retraction notice to "Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression" [Int. Immunopharmacol. 42 (2017) 130-138].
Journal: International immunopharmacology
Published: September 09, 2025
Correction: Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.
Journal: PloS one
Published: December 31, 2024
Comparison of the Efficacy and Safety of Axi-Cel and Tisa-Cel Based on Meta-Analysis.
Journal: Journal of Cancer
Published: June 08, 2024
Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.
Journal: PloS one
Published: June 19, 2023
Corrigendum to "Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells" [Chem. Biol. Interact. 261 (2017) 118-126].
Journal: Chemico-biological interactions
Published: December 19, 2020
Methyl helicterate inhibits hepatic stellate cell activation through downregulating the ERK1/2 signaling pathway.
Journal: Journal of cellular biochemistry
Published: November 12, 2018
Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: May 24, 2017
Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: November 21, 2016
Raf Kinase Inhibitory Protein Down-Expression Exacerbates Hepatic Fibrosis In Vivo and In Vitro.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: September 28, 2016
Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression.
Journal: International immunopharmacology
Published: August 30, 2016
Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells.
Journal: Chemico-biological interactions
Published: June 08, 2016
Last Updated: 09/26/2026